Showing 251-260 of 10484 results for "".
DermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-for-kids-anifrolumab-for-sle-tremfya-in-psa-at-eular/19948/FDA has approved Cosentyx (secukinumab) from Novartis for patients as young as six years old. The 2nd Annual San Diego Dermatology Symposium kicks off as a live Virtual Experience next Friday. A post-hoc analysis of pooled data from the TULIP Phase 3 clinical trials shows that anifrolumab improvesScientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReInjection Tip: Start Superiorly
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/injection-tip-start-superiorly/18358/When using fillers, start superiorly, says Cheryl Burgess, MD. The approach may optimize lift and allow patients to achieve correction with less filler than originally estimated, she says.Surgical Tips from a Mohs Surgeon
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/surgical-tips-from-a-mohs-surgeon/18694/There are many options for healing defects or treating scars after skin cancer excisions. Joel L. Cohen, MD shares tips for success.Travelers Beware: Infectious Skin Dermatoses
https://practicaldermatology.com/topics/general-topics/travelers-beware-infectious-skin-dermatoses/18691/Theodore Rosen, MD and Natasha Mesinkovska, MD talk to Derm Insider host Neal Bhatia, MD about traveler maladies that affect the skin. Drs. Rosen and Mesinkovska run down diagnostic and treatment pearls for conditions ranging from parasitic infections to bed bug bites to emerging infections. They alRich Snippets - What are they, and why you should be using them?
https://practicaldermatology.com/topics/practice-management/what-are-they-and-use-you-should-be-using-them/18862/Rich snippets—those brief descriptions that appear with search engine results—can be essential to improving SEO and growing traffic for your practice. They quickly offer insight about your business. Learn how to use them optimally in this Ekwa Educational video.Social Media: Top Platforms for Your Practice
https://practicaldermatology.com/topics/practice-management/social-media--avereeno/18998/An Ekwa Educational Video (Ekwa.com). What platforms are best for your practice's social media goals? Learn about the options and how to best use them to engage with patients.New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
https://practicaldermatology.com/series/dermwire-tv/new-clinical-guidelines-for-nonmelanoma-skin-cancer-treatment-arctics-biotherapeutics-seeks-new-fda-approval-for-zoryve-foam/26745/In this week’s DermwireTV, new clinical guidelines for nonmelanoma skin cancer treatment; Arcutis Biotherapeutics seeks new FDA approval for ZORYVE foam; Practical Dermatology joins the ReachMD network; and the CEO of SofWave Medical joins us to discuss the company’s Ultrasound technology.JAK Safety and Treating Patients
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37147/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, explains the ongoing role of topical ruxolitinib in practice as the safety of JAK inhibitors is more widJournal Scan of Three Trials for an Rx Option
https://practicaldermatology.com/topics/psoriasis/deucravacitinib-journal-scan/29155/A review of three clinical trials, with introduction and commentary by Linda Stein Gold, MD. Click the image to download the full supplement.